Invicta Diagnostic IPO
INVICTA
Open Date
01 Dec '25
Close Date
03 Dec '25
Price Range
₹80 - ₹85
Min Investment
₹2,72,000
Lot Size
1,600
Listing at
NSE
Issue Size
25,10,400
IPO Document
Free Demat with Zero AMC*
About Invicta Diagnostic Ltd IPO
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra.
Invicta Diagnostics Limited (trading as PC Diagnostics) is a Mumbai-based diagnostic services company specialising in integrated pathology and radiology solutions. The company follows a hub-and-spoke model across the Mumbai Metropolitan Region, featuring:
- A flagship hub in Thane West offering full-spectrum pathology and advanced radiology (PET CT, MRI)
- Three additional hubs (Bhayandar, Byculla, Marol) providing specialised diagnostic services
- Three spokes in Lower Parel, Sewri, and Kalwa focused on basic imaging (X-ray, ultrasound) and sample collection.
The company offers around 60 routine and 487 specialised pathology tests, plus about 96 basic and 130 advanced radiology tests.
Invicta Diagnostics provides a comprehensive suite of diagnostic services, which includes:
- Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
- Specialised Tests: Covers molecular diagnostics, immunoassays, infectious disease markers (e.g., dengue, COVID-19), cancer markers, and genetic panels
- Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres.
As of October 31, 2025, the company employed 157 permanent employees.
Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. The company provides pathology and radiology testing, including imaging, radiology, and teleradiology, under the brand 'PC Diagnostics' through 7 diagnostic centres and a central laboratory across Mumbai, Maharashtra. Invicta Diagnostics Limited (trading as PC Diagnostics ) is a M
Invicta Diagnostic IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 12,55,200 crores |
| Non-Institutional Investors (NIIs) | 15% | 3,76,560 crores |
| Retail Individual Investors (RIIs) | 35% | 8,78,640 crores |
Invicta Diagnostic IPO Strengths & Weaknesses
Expanding presence in the Mumbai Metropolitan Region (“MMR”)
specifically in the radiology sector
A diagnostics provider that offers a one-stop solution at an affordable price
Technical capability and technology with IT infrastructure
Dedicated management team with significant industry experience
Invicta Diagnostic IPO Important Dates & Issue Details
| Allotment Date | Listing Date | Refund Date |
|---|---|---|
| 04 Dec '25 | 08 Dec '25 | 05 Dec '25 |
| Issue Composition: | |
|---|---|
| Face Value | ₹0 per share |
| Total Issue Size | 25,10,400 shares (aggregating up to ₹2,72,000 crores) |
| Fresh Issue | NaN shares (aggregating up to To be announced) |
| Offer for Sale | NaN shares of ₹0 (aggregating up to To be announced) |
| Issue Type | |
| Post-Issue Shareholding Pattern: | |
|---|---|
| Pre-Issue Shareholding | shares |
| Post-Issue Shareholding | 0 shares |
Invicta Diagnostic IPO Lot Size and Investment Details
| Minimum Lot Size | -- |
| Maximum Lot Size (Retail) | -- |
The lot size of Invicta Diagnostic ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Invicta Diagnostic IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
Optivalue Tek Consulting Ltd IPO Lead Manager(s)
| Book Running Lead Manager(s) |
|---|